Safety of Cardiac Pacemakers in 3 Tesla MRI
- Conditions
- Heart Diseases
- Registration Number
- NCT00356330
- Lead Sponsor
- University Hospital, Bonn
- Brief Summary
To evaluate short-term and long-term effects by MR imaging at 3T on the technical and functional status of cardiac pacemakers.
- Detailed Description
Recently, a shift could be observed from cardiac pacemakers being an absolute contraindication to being a relative contraindication for MR imaging at 1.5 Tesla, depending on a patient-per-patient risk-benefit-evaluation, which includes an urgent clinical need for MR imaging (other imaging modalities non-conclusive) and co-morbidities (especially cardiac co-morbidities). At the same time, MR imaging at 3 Tesla is evolving from a research application only to an important imaging modality today.
Using the improved signal-to-noise-ratio, high field MR-Systems with a field strength of 3 Tesla offer a variety of diagnostic advantages to 1.5 Tesla systems. These advantages lead to a higher sensitivity and specificity in diagnosing, foremost neurological, disorders.
In this study, we evaluate the safety of MR imaging of the brain in patients with cardiac pacemakers at 3T.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 75
-
Urgent need for an MRI examination
-
Stable pacemaker physical parameters
- Battery voltage > 2.7 V
- Battery impedance < 2000 Ohm
- Battery estimated remaining lifetime > 6 months
- Lead impedances 200-2000 Ohm
-
Stable pacing parameters
- Pacing capture threshold <2.5V at a pulse duration of 0.4ms
- Sensing > 5mV
-
Minimum 3 months since pacemaker and lead implantation
- History of ventricular tachycardia (VT) or ventricular fibrillation
- Unstable angina
- Myocardial infarction within the previous 3 months
- Cardiothoracic surgery within the previous 3 months
- Presence of an abdominal pacemaker with lead length > 70 cm
- Presence of MRI incompatible bioimplants or other MRI incompatible materials
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Bonn, Department of Radiology
🇩🇪Bonn, NRW, Germany